Phase 2 Inflammatory Bowel Diseases trials recruiting now
All Inflammatory Bowel Diseases trials, every phase
8
Phase 2 recruiting
Other phases for Inflammatory Bowel Diseases
Phase 2 Inflammatory Bowel Diseases trials
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Beta-Hydroxybutyrate Feasibility Treating IBD
- Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
- Metformin as Added on Therapy in Patients With Ulcerative Colitis
- Microbial Restoration in Inflammatory Bowel Diseases
- Pentoxifylline in Patients With Ulcerative Colitis
- Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.